葛蘭素史克GSK
紐約證券 · USD
37.35
+0.20
(+0.54%)
盤中 08/01 10:14 (UTC+8)
08/01 10:14 (UTC+8)
葛蘭素史克GSK
37.35
+0.20
(+0.54%)
財務數據
損益表
- 73.76
- 69.51
- 71.78
- 81.47
- 80.52
- 73.63
- 78.84
- 80.12
- 81.17
- 75.16
- -5.79
- -5.76
- 3.27
- 13.50
- -1.17
- -8.56
- 7.08
- 1.62
- 1.31
- -7.40
- 營業收入(億)
- 季增長率(%)
單位：美元千元
2025/Q1 | 2024/Q4 | 2024/Q3 | 2024/Q2 | 2024/Q1 | 2023/Q4 | 2023/Q3 | 2023/Q2 | 2023/Q1 | 2022/Q4 | |
營業收入淨額 | 7,516,000 | 8,117,000 | 8,012,000 | 7,884,000 | 7,363,000 | 8,052,000 | 8,147,000 | 7,178,000 | 6,951,000 | 7,376,000 |
營業成本 | 1,937,000 | 2,559,000 | 2,397,000 | 2,122,000 | 1,970,000 | 2,418,000 | 2,272,000 | 1,932,000 | 1,943,000 | 2,238,000 |
營業毛利 | 5,579,000 | 5,558,000 | 5,615,000 | 5,762,000 | 5,393,000 | 5,634,000 | 5,875,000 | 5,246,000 | 5,008,000 | 5,138,000 |
營業費用 | 3,363,000 | 3,341,000 | 5,426,000 | 4,116,000 | 3,903,000 | 4,461,000 | 3,926,000 | 3,105,000 | 2,926,000 | 2,974,000 |
研發費用 | 1,462,000 | 2,031,000 | 1,459,000 | 1,477,000 | 1,434,000 | 2,047,000 | 1,575,000 | 1,341,000 | 1,260,000 | 1,797,000 |
推銷及管理費用 | 2,070,000 | 2,663,000 | 3,800,000 | 2,465,000 | 2,087,000 | 2,678,000 | 2,296,000 | 2,268,000 | 2,143,000 | 2,438,000 |
非經常性項目費用 | - | - | - | - | - | - | - | - | - | - |
其他營業費用 | 11,000 | -1,177,000 | 335,000 | 318,000 | 533,000 | - | 367,000 | - | - | - |
營業利益 | 2,216,000 | 2,217,000 | 189,000 | 1,646,000 | 1,490,000 | 1,173,000 | 1,949,000 | 2,141,000 | 2,082,000 | 2,164,000 |
其他收入及費用 | - | - | - | - | - | - | - | - | - | - |
利息費用 | 162,000 | 144,000 | 156,000 | 174,000 | 166,000 | 155,000 | 182,000 | 185,000 | 203,000 | 217,000 |
稅前純益 | 2,108,000 | 563,000 | 64,000 | 1,495,000 | 1,355,000 | 379,000 | 1,791,000 | 1,987,000 | 1,907,000 | 1,626,000 |
所得稅 | 336,000 | 62,000 | -1,000 | 191,000 | 274,000 | -19,000 | 257,000 | 242,000 | 276,000 | 1,000 |
稅後純益 | 1,624,000 | 414,000 | -58,000 | 1,173,000 | 1,046,000 | 350,000 | 1,464,000 | 1,624,000 | 1,490,000 | 1,461,000 |
基本每股稅後盈餘(元) | 0.79 | 0.20 | -0.03 | 0.58 | 0.51 | 0.17 | 0.72 | 0.64 | 0.74 | 0.74 |
稀釋每股稅後盈餘(元) | 0.79 | 0.20 | -0.03 | 0.57 | 0.51 | 0.17 | 0.71 | 0.64 | 0.73 | 0.73 |
基本平均股數(千股) | 2044000.00 | 2040500.00 | 2040000.00 | 2039500.00 | 2034500.00 | 2028000.00 | 2027500.00 | 2533125.00 | 2022000.00 | 2017000.00 |
稀釋平均股數(千股) | 2068500.00 | 2072500.00 | 2070500.00 | 2061000.00 | 2056500.00 | 2058000.00 | 2056000.00 | 2558125.00 | 2042500.00 | 2045500.00 |
還原基本每股稅後盈餘(元) | 0.79 | 0.20 | -0.03 | 0.58 | 0.51 | 0.17 | 0.72 | 0.64 | 0.74 | 0.74 |
還原稀釋每股稅後盈餘(元) | 0.79 | 0.20 | -0.03 | 0.57 | 0.51 | 0.17 | 0.71 | 0.64 | 0.73 | 0.73 |
還原基本平均股數(千股) | 2,044,000 | 2,040,500 | 2,040,000 | 2,039,500 | 2,034,500 | 2,028,000 | 2,027,500 | 2,533,125 | 2,022,000 | 2,017,000 |
還原稀釋平均股數(千股) | 2,068,500 | 2,072,500 | 2,070,500 | 2,061,000 | 2,056,500 | 2,058,000 | 2,056,000 | 2,558,125 | 2,042,500 | 2,045,500 |
EBITDA(千元) | 2,122,000 | 620,000 | 97,000 | 1,538,000 | 1,486,000 | 486,000 | 1,903,000 | 2,051,000 | 1,969,000 | 1,679,000 |